YEP-62600-02108

3 vaccinations 9 coded responses 29 check-ins 9 free-text entries 3 call cases

Sex: Female
Age at first dose: 46-50
ZIP prefix: 128 / NY
Registered: 2021-03-10

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-17
Dose 1 — Pfizer-BioNTech
2021-03-10
Registered in v-safe
2021-03-10
Dose 2 — Pfizer-BioNTech
2021-03-10
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain, Swelling · None

Adult check-in
2021-03-11
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness, Myasthenia gravis, Pre-existing disease — Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness

Free text: I have had Myasthenia Gravis for a few years. Symptoms had remitted to my new baseline prior to this dose. I am having a mild return of MG symptoms but tolerable without treatment so far. Mild intermittent dizziness also this morning that has resolved.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-12
Survey response — days 1–6 daily, dose 2
MedDRA: Eyelid ptosis — Feeling: Good · Site: Pain, Swelling · Muscle or body aches

Free text: Mild ptosis early morning lasting approx 10min which resolved without need for medication. History of Myasthenia Gravis

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-14
Survey response — days 1–6 daily, dose 2
MedDRA: Chills, Hyperhidrosis, Myasthenia gravis, Pre-existing disease — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Alternating chills and sweats throughout last night but no fever. Myasthenia Gravis symptoms have returned but may be unrelated to the vaccine.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-15
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Muscle or body aches

Adult check-in
2021-03-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-17
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-03-24
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-03-31
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-04-07
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-04-14
Survey response — day 35, dose 2
MedDRA: Dysarthria, Eyelid ptosis, Fatigue, Myasthenia gravis, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities

Free text: Flare of pre-existing Myasthenia Gravis...increased ptosis, fatigue, slurred speech

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-21
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-06-09
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-09-08
Survey response — 6 months, dose 2
MedDRA: Allergic respiratory symptom, Anal incontinence, Dermatitis allergic, Dermatitis contact, Foaming at mouth, Hospitalisation, Hypersensitivity, Myasthenia gravis, Pre-existing disease, Unresponsive to stimuli, Urticaria, Wheezing — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization

Free text: Symptoms: Hypersensitivity reactions to a variety of stimuli not previously allergic to including skin reactions to adhesives, hives & wheezing with no known trigger, severe reaction to plasmapheresis (unresponsive, foaming at mouth, loss of bowels), MG flare · Healthcare visit (other): Hospital admission and transfer to larger facility by ambulance

MedDRA releases: 2024-11 · check-in free text available
2021-09-08
Report sent to call center — 6 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-09-11
Call successful
Participant prefers to complete VAERS report online
2021-11-03
Dose 3 — Pfizer-BioNTech
2021-11-05
Survey response — days 1–6 daily, dose 3
MedDRA: Myasthenia gravis, Pre-existing disease — Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Mild increased Myasthenia Gravis symptoms

MedDRA releases: 2024-11 · check-in free text available
2021-11-06
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-07
Survey response — days 1–6 daily, dose 3
MedDRA: Urticaria — Feeling: Fair · Fatigue or tiredness, Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Hives on right upper chest not related to exposure to known allergen. No changes to soaps, detergents or clothing

MedDRA releases: 2024-11 · check-in free text available
2021-11-07
Report sent to call center — days 1–6 daily, dose 3
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2021-11-08
Survey response — days 1–6 daily, dose 3
MedDRA: Myasthenia gravis, Pre-existing disease — Feeling: Fair · Headache, Fatigue or tiredness

Free text: Mild Myasthenia Gravis flare

MedDRA releases: 2024-11 · check-in free text available
2021-11-09
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site

Adult check-in
2021-11-09
Call 1 — Requested Callback
2021-11-11
Health check-in — day 7, dose 3
Feeling: Good · Headache, Rash, not including the immediate area around the injection site

Adult check-in
2021-11-16
Call 2 — Left Voicemail
2021-11-16
Callback requested for
10:00AM ET
2021-11-17
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-11-24
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-12-01
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-12-08
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2021-12-15
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-02-02
Survey response — 3 months, dose 3
MedDRA: Chronic spontaneous urticaria, Sjogren's syndrome — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Diagnosed with Autoimmune Urticaria and Sjogrens

MedDRA releases: 2024-11 · check-in free text available
2022-02-02
Report sent to call center — 3 months, dose 3
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-02-03
Call 1 — Left Voicemail
2022-02-04
Call 2 — Left Voicemail
2022-05-04
Health check-in — 6 months, dose 3
Feeling: Fair

Adult check-in
2022-11-03
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-17	Pfizer-BioNTech
2	2021-03-10	Pfizer-BioNTech
3	2021-11-03	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-09-08	Successful 2021-09-11	Participant prefers to complete VAERS report online
2021-11-07	Unsuccessful
2022-02-02	Unsuccessful

Free text

Release 5 — days 1–6 daily, dose 2

2021-03-11

Systemic reaction (other): I have had Myasthenia Gravis for a few years. Symptoms had remitted to my new baseline prior to this dose. I am having a mild return of MG symptoms but tolerable without treatment so far. Mild intermittent dizziness also this morning that has resolved.

2021-03-12

Systemic reaction (other): Mild ptosis early morning lasting approx 10min which resolved without need for medication. History of Myasthenia Gravis

2021-03-14

Systemic reaction (other): Alternating chills and sweats throughout last night but no fever. Myasthenia Gravis symptoms have returned but may be unrelated to the vaccine.

Release 7 — day 35, dose 2

2021-04-14

Symptoms: Flare of pre-existing Myasthenia Gravis...increased ptosis, fatigue, slurred speech

Release 9 — 6 months, dose 2

2021-09-08

Symptoms: Hypersensitivity reactions to a variety of stimuli not previously allergic to including skin reactions to adhesives, hives & wheezing with no known trigger, severe reaction to plasmapheresis (unresponsive, foaming at mouth, loss of bowels), MG flare cut off by CDC

Healthcare visit (other): Hospital admission and transfer to larger facility by ambulance

Release 10 — days 1–6 daily, dose 3

2021-11-05

Systemic reaction (other): Mild increased Myasthenia Gravis symptoms

2021-11-07

Systemic reaction (other): Hives on right upper chest not related to exposure to known allergen. No changes to soaps, detergents or clothing

2021-11-08

Systemic reaction (other): Mild Myasthenia Gravis flare

Release 11 — 3 months, dose 3

2022-02-02

Symptoms: Diagnosed with Autoimmune Urticaria and Sjogrens

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Hospitalisation	·	·	✓
SD	Allergic respiratory symptom	·	·	✓
SD	Anal incontinence	·	·	✓
SD	Chronic spontaneous urticaria	·	·	✓
SD	Dermatitis allergic	·	·	✓
SD	Dermatitis contact	·	·	✓
SD	Dysarthria	✓	✓	✓
SD	Eyelid ptosis	✓	✓	✓
SD	Fatigue	✓	✓	✓
SD	Foaming at mouth	·	·	✓
SD	Hypersensitivity	·	·	✓
SD	Myasthenia gravis	✓	✓	✓
SD	Pre-existing disease	✓	✓	✓
SD	Sjogren's syndrome	·	·	✓
SD	Unresponsive to stimuli	·	·	✓
SD	Urticaria	·	·	✓
SD	Wheezing	·	·	✓
SRO	Chills	✓	✓	✓
SRO	Dizziness	✓	✓	✓
SRO	Eyelid ptosis	✓	✓	✓
SRO	Hyperhidrosis	✓	✓	✓
SRO	Myasthenia gravis	✓	✓	✓
SRO	Pre-existing disease	✓	✓	✓
SRO	Urticaria	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release